RANI
RANI
NASDAQ · Pharmaceuticals

Rani Therapeutics Holdings-A

$1.06
-0.08 (-7.02%)
As of Mar 24, 10:09 PM ET ·
RANI News11 articles
Denison Mines Gains on Partner's Uranium Find, Phoenix Mine Development Advances
Denison Mines shares advanced after joint venture partner Cosa Resources reported a significant radioactive intercept at the Murphy Lake North project. Concurrently, Denison is moving forward with site preparation for its major Phoenix in-situ recovery uranium mine.
Commodities
Denison Mines Advances Phoenix Uranium Project as Shares Climb
Denison Mines shares gained 3% as the company moves from permitting to construction at its Phoenix in-situ recovery uranium project. The mine is Canada's first major uranium construction approval in over two decades.
Commodities
U.S. Weighs Sanctions Waiver to Unlock 140M Barrels of Iranian Oil
The U.S. Treasury is considering a temporary sanctions waiver to release approximately 140 million barrels of Iranian oil currently stranded on tankers. This move aims to calm markets following Iran's closure of the Strait of Hormuz, a critical oil chokepoint.
Commodities
Denison Mines Shares Slide as Phoenix Uranium Mine Construction Approved
Denison Mines shares declined following board approval to construct the Phoenix uranium mine in Saskatchewan, with the company reporting a substantial 2025 net loss and significant debt.
Commodities
Denison Mines Advances Phoenix Uranium Project, Shares Gain
Denison Mines shares climbed 1.2% after announcing the start of site preparation at its Phoenix uranium project in Saskatchewan, following final federal approval. The company targets first production by mid-2028.
Commodities
Denison Mines Shares Slide Amid Phoenix Uranium Project Cost Revisions
Denison Mines Corp. shares declined 6.3% to $3.58, underperforming the broader market, following an increased capital estimate for its flagship Phoenix uranium project. The company reported a significant 2025 net loss of $217.3 million against modest revenue.
Commodities
Denison Mines Reports 2025 Loss as Phoenix Uranium Project Construction Begins
Denison Mines Corp. shares fell 1.6% following its 2025 financial results, which showed a widened net loss of C$217.3 million. The company confirmed it will begin construction this month on its Phoenix uranium project, targeting first production by mid-2028.
Earnings
Denison Mines Launches Major Exploration as Phoenix Uranium Mine Construction Begins
Denison Mines Corp. has initiated a significant 7,500-meter drill program at its Wheeler North joint venture in Saskatchewan, coinciding with the start of construction at its flagship Phoenix uranium mine, which received final regulatory approval.
Commodities
Denison Mines Approves Construction of Phoenix ISR Uranium Mine, Targets 2028 Production
Denison Mines Corp. has received board approval to commence construction of the Phoenix in-situ recovery uranium mine in Saskatchewan, with site preparation scheduled to begin in March 2026. The company targets first production by mid-2028 at an estimated capital cost of C$600 million.
Commodities
Denison Mines Secures Key Canadian Approval for Phoenix Uranium Mine
Denison Mines Corp. shares advanced in premarket trading following Canadian regulatory approval for construction of its flagship Phoenix uranium mine. The decision shifts focus to the company's final investment decision and construction timeline.
Commodities
Paladin Energy Gains on Key Canadian Uranium Project Approval
Paladin Energy Ltd. advanced after receiving provincial environmental sign-off for its Patterson Lake South uranium project in Canada. The approval marks a key regulatory milestone as the company progresses toward federal licensing.
Commodities